Janssen Presents Results from Phase 3 ACIS
The Pharma Data
FEBRUARY 8, 2021
Food and Drug Administration (FDA) approval for nmCRPC on February 14, 2018 and was approved for mCSPC on September 17, 2019. About the Janssen Pharmaceutical Companies of Johnson & Johnson. Janssen Research & Development, LLC is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. # # #.
Let's personalize your content